Hiroki Iwanishi

Dr. Hiroki Iwanishi


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Experimental Eye Research
Verified
Journal Article
Closed access
SMShin Mizoguchi
Shin Mizoguchi
HIHiroki Iwanishi
Hiroki Iwanishi
RAReiko Arita
Reiko Arita
KSKumi Shirai
Kumi Shirai
TSTakayoshi Sumioka
Takayoshi Sumioka
SSShizuya Saika
Shizuya Saika

1 October 2017 in The Ocular Surface
Verified
Journal Article
Closed access
SMShin Mizoguchi
Shin Mizoguchi
HIHiroki Iwanishi
Hiroki Iwanishi
MKMasahide Kokado
Masahide Kokado
TSTakayoshi Sumioka
Takayoshi Sumioka
GPGeraint J. Parfitt
Geraint J. Parfitt
SSShizuya Saika
Shizuya Saika

29 April 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
KIKazuki Imai
Kazuki Imai
TSTakayoshi Sumioka
Takayoshi Sumioka
HIHiroki Iwanishi
Hiroki Iwanishi
YTYukihisa Takada
Yukihisa Takada
SMShin’ichi Murata
Shin’ichi Murata
SSShizuya Saika
Shizuya Saika
Background: Corneal infection of Colletotrichum gloeosporioides is uncommon and usually limited to the anterior stroma. However, we observed a case of corneal stromal perforation caused by this fungus under a compromised condition. Case: A 73-year-old woman consulted us with a severe corneal ulceration. She was a tangerine orange farmer who suffered from rheumatoid arthritis for more than ten years. Before consultation with us, she received pterygium excision in her right eye. She then developed a corneal ulceration and received topical glucocorticoid therapy upon diagnosis of rheumatoid arthritis-related stromal ulcer in the eye. At the first consultation with us, a corneal ulceration was observed in the inferotemporal area of her right cornea. Biological examination detected a filamentous fungus, Colletotrichum gloeosporioides. Topical and systemic antifungal treatments were not significantly effective. Fourteen days after consultation, the lesion grew worse, leading to stromal perforation, which was treated by therapeutic penetrating keratoplasty using a preserved corneal button. Conclusions: Topical glucocorticoid could accelerate the growth of Colletotrichum gloeosporioides before diagnosis, even though the primary cause of corneal ulceration development might be rheumatoid arthritis.

20 September 2022 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
HIHiroki Iwanishi
Hiroki Iwanishi
OYOsamu Yamanaka
Osamu Yamanaka
TSTakayoshi Sumioka
Takayoshi Sumioka
SYShingo Yasuda
Shingo Yasuda
MMMasayasu Miyajima
Masayasu Miyajima
SSShizuya Saika
Shizuya Saika
We investigated the effects of lacking TNFα on the development and regression of Argon‐laser‐induced choroidal neovascularization (CNV) in mice. We lasered ocular fundus for induction of CNV in both wild‐type (WT) and TNFα‐null (KO) mice. Fluorescence angiography was performed to examine the size of CNV lesions. Gene expression pattern of wound healing‐related components was examined. The effects of exogenous TNFα on apoptosis of human retinal microvascular endothelial cells (HRMECs) and on the tube‐like structure of the cells were investigated in vitro. The results showed that Argon‐laser irradiation‐induced CNV was significantly larger in KO mice than WT mice on Day 21, but not at other timepoints. Lacking TNFα increased neutrophil population in the lesion. The distribution of cleaved caspase3‐labelled apoptotic cells was more frequently observed in the laser‐irradiated tissue in a WT mouse as compared with a KO mouse. Exogenous TNFα induced apoptosis of HRMECs and accelerated regression of tube‐like structure of HRMECs in cell culture. Taken together, TNFα gene knockout delays the regression of laser‐induced CNV in mice. The mechanism underlying the phenotype might include the augmentation of neutrophil population in the treated tissue and attenuation of vascular endothelial cell apoptosis.

28 August 2023 in Archives of Plastic Surgery
Verified
Journal Article
Open access
PDF file
YSYuji Shirakawa
Yuji Shirakawa
UKUemura Kazuhisa
Uemura Kazuhisa
SKShinji Kumegawa
Shinji Kumegawa
KUKazuki Ueno
Kazuki Ueno
HIHiroki Iwanishi
Hiroki Iwanishi
SAShinichi Asamura
Shinichi Asamura
Background Elderly patients often have complications of blepharoptosis surgery that can result in the appearance or exacerbation of superficial punctate keratopathy (SPK). However, postoperative changes to SPK status have not been previously reported. We used subjective assessment of symptoms and measurement of SPK scale classification to investigate the safety and efficacy of blepharoptosis surgery in elderly patients. Methods Included in this prospective study were 22 patients (44 eyes) with bilateral blepharoptosis that underwent surgery. Patients comprised 8 males and 14 females with a mean (±standard deviation) age of 75.7 ± 8.2 years (range: 61–89). Blepharoptosis surgery consisted of transcutaneous levator advancement and blepharoplasty including resection of soft tissue (skin, subcutaneous tissue, and the orbicularis oculi muscle). Margin reflex distance-1 (MRD-1) measurement, a questionnaire survey of symptoms and SPK scale classification, was administered preoperatively and 3 months postoperatively for evaluation. Results The median MRD-1 was 1 mm preoperatively and 2.5 mm postoperatively, representing a significant postoperative improvement. SPK area and density scores were found to increase when the MRD-1 increase was more than 2.5 mm with surgery. All 10 items on the questionnaire tended have increased scores after surgery, and significant differences were observed in 7 items (poor visibility, ocular fatigue, heavy eyelid, foreign body sensation, difficulty in focusing, headaches, and stiff shoulders). Conclusion Blepharoptosis surgery was found to be a safe and effective way to maintain the increase in MRD-1 within 2.0 mm. Despite the benefits, surgeons must nonetheless be aware that blepharoptosis surgery is a delicate procedure in elderly people.

9 August 2023 in Laboratory Investigation
Verified
Journal Article
Open access
YUYuta Usui
Yuta Usui
HIHiroki Iwanishi
Hiroki Iwanishi
TSTakayoshi Sumiok
Takayoshi Sumiok
KIKana Ichikawa
Kana Ichikawa
MMMasayasu Miyajima
Masayasu Miyajima
SSShizuya Saika
Shizuya Saika
We examined the effects of gene ablation and chemical inhibition of transient receptor potential ankyrin 1 (TRPA1) on the growth of experimental argon laser-induced choroidal neovascularization (CNV) in mice. CNV was induced in the eyes of 6 - 8-week-old mice by argon laser irradiation and observed expression. This reaction was compared between TRPA1-null (KO) mice and wild-type (WT) mice. Gene expression analysis was performed in laser-injured tissues on day 1 and 3. CNV growth was evaluated on day 14. Finally, reciprocal bone marrow transplantation was performed between each genotype of mice to identify the responsible components of either recipient tissue or bone marrow-derived inflammatory cells. Results showed that laser irradiation successfully induced CNV growth at the site of laser injury. The size of induced CNV was significantly smaller in KO mice as compared with WT mice at day 14, as examined by angiography with fluorescein isothiocyanate-dextran. Invasion of neutrophils, but not macrophages, was suppressed in association with suppression of expression of transforming growth factor β1 in laser-irradiated KO tissues. Bone marrow transplantation indicated that the genotype of the recipient mouse, but not of inflammatory cells, is attributable to the KO phenotype. Systemic administration of a TRPA1 antagonist also downsized the CNV in a WT mouse. In conclusion, TRPA1 signal in local tissue cells is involved in the growth of laser-induced CNV. The phenotype was not attributable to both vascular endothelial cells and inflammatory cells. Blocking TRPA1 signal could be a potential treatment strategy for CNV-related ocular diseases. (244 words).